Feedback plc
Total Voting Rights
Cambridge, 30 August 2019: Feedback plc (AIM: FDBK, "Feedback" or the "Company") announces that the Company's issued share capital, as at the date of this announcement, comprises 539,949,917 ordinary shares, with one voting right per share ("Ordinary Shares"). The Company does not hold any ordinary shares in treasury. Therefore, the total number of ordinary shares and voting rights in the Company is 539,949,917.
The above figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.
Enquiries:
|
|
Feedback plc Tom Oakley, CEO Lindsay Melvin, CFO
|
+44 (0)1954 718072 |
Allenby Capital Limited (Nominated Adviser) David Worlidge / Asha Chotai
|
+44 (0)20 3328 5656 |
Peterhouse Capital Limited (Joint Broker) Lucy Williams / Duncan Vasey
|
+44 (0)20 7469 0936 |
Stanford Capital Partners Limited (Joint Broker) Patrick Claridge / John Howes
Instinctif Partners Rozi Morris / Phillip Marriage |
+44 20 3815 8880
+44 (0)20 7457 2020 |
Notes to editors
About Feedback plc
Feedback plc (AIM: FDBK) is a specialist medical imaging technology company providing innovative software and systems, through its fully-owned trading subsidiary, Feedback Medical Limited. Its products advance the work of radiologists, clinicians and medical researchers by improving workflows and giving unique insights into diseases, particularly cancer. Feedback Medical works with customers globally from headquarters in the internationally renowned scientific hub of Cambridge, UK. Its proprietary technologies are TexRAD®, the quantitative texture analysis tool and Cadran, a picture archiving communication system (PACS). The Company has recently announced the launch of its new messaging and image transfer product Bleepa™. For more information, see www.fbk.com